NR3C2 and Pelizeaus-Merzbacher spectrum disorder: Recently Lembke et al. (49) published a study showing that individuals with PMD compared to healthy control subjects have diminished feedback inhibition of the HPA axis in response to the MR agonist fludrocortisone (49).